Myeloid DNA methyltransferase 3A loss impairs macrophage polarization and promotes inflammation, phagocytosis and hepatosplenomegaly
Background: Genetic variants in the de novo DNA methyltransferase DNMT3A increase inflammatory bowel disease (IBD) risk, yet the mechanisms linking defective DNMT3A to IBD remain unclear. As macrophages gatekeep immune homeostasis, we characterized how myeloid-specific DNMT3A loss affects monocytic differentiation and inflammatory properties. Methods: We generated myeloid-specific…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.